Stock Events

Stock Events

Alnylam Pharmaceuticals (A1LN34.SA) Q2 2016 Earnings

2MayConfirmed

Q3 2015

Q4 2015

Q1 2016

Q2 2016

-4.27

-3.71

-3.16

-2.61

Details

Expected EPS

-3.7761120000000004

Actual EPS

-4.230644

Surprise EPS

-0.45

Surprise Percent

+12.04%

Description

Alnylam Pharmaceuticals (A1LN34.SA) has reported earnings of -4.230644 per share for Q2 2016.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.